Lin Xiang, Yang Xinyu, Yang Yushang, Zhang Hangbin, Huang Xuan
The First Clinical College, Zhejiang Chinese Medical University, Hangzhou, China.
Department of Gastroenterology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Front Oncol. 2023 Mar 13;13:1132141. doi: 10.3389/fonc.2023.1132141. eCollection 2023.
In recent years, the incidences and mortalities from colorectal cancer (CRC) have been increasing; therefore, there is an urgent need to discover newer drugs that enhance drug sensitivity and reverse drug tolerance in CRC treatment. With this view, the current study focuses on understanding the mechanism of CRC chemoresistance to the drug as well as exploring the potential of different traditional Chinese medicine (TCM) in restoring the sensitivity of CRC to chemotherapeutic drugs. Moreover, the mechanism involved in restoring sensitivity, such as by acting on the target of traditional chemical drugs, assisting drug activation, increasing intracellular accumulation of anticancer drugs, improving tumor microenvironment, relieving immunosuppression, and erasing reversible modification like methylation, have been thoroughly discussed. Furthermore, the effect of TCM along with anticancer drugs in reducing toxicity, increasing efficiency, mediating new ways of cell death, and effectively blocking the drug resistance mechanism has been studied. We aimed to explore the potential of TCM as a sensitizer of anti-CRC drugs for the development of a new natural, less-toxic, and highly effective sensitizer to CRC chemoresistance.
近年来,结直肠癌(CRC)的发病率和死亡率一直在上升;因此,迫切需要发现更新的药物,以提高CRC治疗中的药物敏感性并逆转耐药性。基于此观点,当前的研究集中于了解CRC对药物产生化学抗性的机制,以及探索不同中药在恢复CRC对化疗药物敏感性方面的潜力。此外,还深入讨论了恢复敏感性所涉及的机制,例如作用于传统化学药物的靶点、协助药物激活、增加抗癌药物的细胞内积累、改善肿瘤微环境、缓解免疫抑制以及消除甲基化等可逆修饰。此外,还研究了中药与抗癌药物联合使用在降低毒性、提高疗效、介导新的细胞死亡方式以及有效阻断耐药机制方面的作用。我们旨在探索中药作为抗CRC药物增敏剂的潜力,以开发一种新的天然、低毒且高效的CRC化学抗性增敏剂。